Trial Profile
A randomized, double-blind, split-face study to evaluate efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hypertrophy
- Focus Therapeutic Use
- 06 Dec 2015 New trial record